Skip to main content
StrykerNews

Stryker earns FDA clearance for new bone and soft tissue removal platform

Source: Autobound Signal API · 121 signals tracked for Stryker · updated

Get Stryker's live signals in Claude or ChatGPT, or by API

AskWhat changed at Stryker this week? Use Autobound signals for stryker.com.

What happened

Stryker Chief Operating Officer Spencer Stiles will become the company's next CEO.

Source

Article excerpt

Sonopet 3 features enhancements to the company’s Sonopet offerings, such as pulse control, which gives providers added ability to regulate hard and soft tissue resection and Stryker’s Reimagined Integrated Surgical Experience (RISE) technology for a connected surgical workflow. Stryker said it developed the advanced platform with input from hundreds of surgeons who informed key performance improvements, workflow efficiency and clinical priorities. “At Stryker, innovation begins with listening to our customers,” Stryker Neurosurgical VP and GM Mitch Foley said in the announcement. “Every major advancement in Sonopet 3 can be attributed to surgeon feedback, and together we’re elevating the standard in neurosurgery. “They told us they wanted more power, improved ergonomics and enhanced integration, helping them perform with confidence in demanding surgical environments,” he continued. Read more about the world’s largest medtech companies in our 2026 Medtech Big 100 issue of Medical Design & Outsourcing Stryker expects the first clinical cases using the platform to begin this month, with a full commercial launch planned for later this fall. As the orthopedics company expands platforms like Sonopet, it recently invested $400 million in CMR Surgical and entered the soft-tissue robotics market. In the deal, Stryker gains exclusive rights to sell CMR’s Versius platform in the...

Keep reading with a free account

The rest of this article, and every signal for Stryker, is in your free account.

Extracted from this sentence

Stryker Chief Operating Officer Spencer Stiles will become the company’s next CEO, and Lobo will continue to serve as executive chair.

Extracted by Autobound

From the Signal API record
Event
News

What this signalsA newly promoted leader often gets the budget to change how the team works.

Person
Spencer StilesCEO

The full record

From the Signal API record

People

  • Spencer StilesCEO · Named in the story

Topics and mentions

Job title tags

  • directors
  • management

Extraction

Confidence
95%
Detected
Oct 15, 2026
signal_type
news
signal_subtype
promotes

Use this data

Get every news signal for Stryker and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Stryker this week?”

  2. Send it to your own tools

    The Signal API returns news signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/1675bd6f-1b33-e17d-45b0-37f0d8eff10c returns this record as JSON. POST /v1/companies/enrich returns every signal for stryker.com.

{
  "signal_id": "1675bd6f-1b33-e17d-45b0-37f0d8eff10c",
  "signal_type": "news",
  "signal_subtype": "promotes",
  "detected_at": "2026-10-15T16:02:01+00:00",
  "company": {
    "name": "Stryker",
    "domain": "stryker.com"
  },
  "data": {
    "url": "https://www.massdevice.com/stryker-fda-510k-clearance-sonopet-3-platform/",
    "title": "Stryker earns FDA clearance for new bone and soft tissue removal platform - MassDevice",
    "contact": "Spencer Stiles",
    "excerpt": "Sonopet 3 features enhancements to the company’s Sonopet offerings, such as pulse control, which gives providers added ability to regulate hard and soft tissue resection and Stryker’s Reimagined Integrated Surgical Experience (RISE) technology for a connected surgical workflow. Stryker said it developed the advanced platform with input from hundreds of surgeons who informed key performance improvements, workflow efficiency and clinical priorities. “At Stryker, innovation begins with listening to our customers,” Stryker Neurosurgical VP and GM Mitch Foley said in the announcement . “Every major advancement in Sonopet 3 can be attributed to surgeon feedback, and together we’re elevating the standard in neurosurgery. “They told us they wanted more power, improved ergonomics and enhanced integration, helping them perform with confidence in demanding surgical environments,” he continued. Read more about the world’s largest medtech companies in our 2026 Medtech Big 100 issue of Medical Design & Outsourcing Stryker expects the first clinical cases using the platform to begin this month, with a full commercial launch planned for later this fall. As the orthopedics company expands platforms like Sonopet, it recently invested $400 million in CMR Surgical and entered the soft-tissue robotics market. In the deal, Stryker gains exclusive rights to sell CMR’s Versius platform in the United...",
    "summary": "Stryker Chief Operating Officer Spencer Stiles will become the company's next CEO.",
    "planning": false,
    "image_url": "https://wtwh-marketing.s3.amazonaws.com/wp-content/uploads/massdevice/2026/10/15115351/Stryker-Sonopet-3-web.jpg",
    "job_title": "CEO",
    "confidence": 0.95,
    "published_at": "2026-10-15T16:02:01Z",
    "job_title_tags": [
      "directors",
      "management"
    ],
    "article_sentence": "Stryker Chief Operating Officer Spencer Stiles will become the company’s next CEO, and Lobo will continue to serve as executive chair."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.